These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 15295300)
21. Hormone therapy and estrogen receptor expression in breast cancer. Friman EI; Mahlman M; Nilsson B; Skoog L; Löfgren L; Wilking N; Von Schoultz E Acta Oncol; 2007; 46(2):194-8. PubMed ID: 17453368 [TBL] [Abstract][Full Text] [Related]
22. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk]. von Schoultz B Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143 [No Abstract] [Full Text] [Related]
23. Therapeutic controversy: Hormone replacement therapy--where are we going? Santoro NF; Col NF; Eckman MH; Wong JB; Pauker SG; Cauley JA; Zmuda J; Crawford S; Johannes CB; Rossouw JE; Merz CN J Clin Endocrinol Metab; 1999 Jun; 84(6):1798-812. PubMed ID: 10372666 [No Abstract] [Full Text] [Related]
24. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758 [TBL] [Abstract][Full Text] [Related]
25. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same]. Ribot C; Trémollieres F Gynecol Obstet Fertil; 2007 May; 35(5):388-97. PubMed ID: 17392010 [TBL] [Abstract][Full Text] [Related]
26. Controversies over hormone replacement therapy. HRT as a risk factor of breast cancer in postmenopausal women. Licznerska BE; Baer-Dubowska W Acta Pol Pharm; 2005; 62(3):241-7. PubMed ID: 16193819 [TBL] [Abstract][Full Text] [Related]
27. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. Banks E; Canfell K Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078 [TBL] [Abstract][Full Text] [Related]
28. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897 [TBL] [Abstract][Full Text] [Related]
29. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study. Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY; Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166 [No Abstract] [Full Text] [Related]
30. Hormone use of questionable benefit in women with heart disease. Health News; 1998 Sep; 4(11):5. PubMed ID: 9745389 [No Abstract] [Full Text] [Related]
31. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results. Kuhl H; Stevenson J Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155 [TBL] [Abstract][Full Text] [Related]
32. Postmenopausal hormone therapy and breast cancer. Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723 [TBL] [Abstract][Full Text] [Related]
34. Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force. U.S. Preventive Services Task Force Ann Intern Med; 2005 May; 142(10):855-60. PubMed ID: 15897536 [TBL] [Abstract][Full Text] [Related]
35. Re: Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. Wood C; Cline M J Natl Cancer Inst; 2008 Sep; 100(18):1335; author reply 1335-6. PubMed ID: 18780867 [No Abstract] [Full Text] [Related]
36. Hormone therapy in postmenopausal and perimenopausal women. Magee SR; Taylor JS Am Fam Physician; 2006 Nov; 74(9):1501-3. PubMed ID: 17111886 [No Abstract] [Full Text] [Related]
37. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY; Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934 [TBL] [Abstract][Full Text] [Related]
39. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial. McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS; J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858 [TBL] [Abstract][Full Text] [Related]
40. Rationale for use of lower estrogen doses for postmenopausal hormone therapy. Ettinger B Maturitas; 2007 May; 57(1):81-4. PubMed ID: 17383126 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]